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This editorial refers to ‘Epicardial function of canonical Wnt-,
Hedgehog-, Fgfr1/2-, and Pdgfra-signalling’ by C. Rudat et al.,
pp. 411–421, this issue.
Among the many important aspects of cardiac development, formation
of the epicardium and the underlining signalling pathways that direct
the mobilization and differentiation of epicardial cells have been one
of the highly pursued research subjects within the past decade. These
epicardium-derived cells (EPDCs) are reported to contribute to
several critical cell types which include cardiac myofibroblasts and
coronary smoothmuscle contributing to the formation of the coronary
vasculature network within the developing embryonic heart.1 Recent
data suggesting that epicardial progenitor cells (EPCs) can contribute
to newly formed cardiomyocytes in injured hearts2,3 has drawn
further attention into the mechanisms of epicardiogenesis, as the suc-
cessful use of epicardial cells in cell replacement therapies will undoubt-
edly have a high clinical impact on treating heart disease. To achieve this
goal, a better understanding of the molecular mechanism that drive
epicardiogenesis will be required.
As the outermost cell layer of the vertebrate heart, the epicardium is
derived from the proepicardial organ (PE), which originates from
splanchnic mesenchyme within the septum transversum that is juxta-
posed near the venous pole of the embryonic day 9.5 (E9.5) mouse
heart (E22 for human). EPCsdetach fromthePE,migrate intopericardial
cavity, andadhere to themyocardial surfacewhere theyrapidlyspread to
form a mesothelial monolayer covering the atria, atrioventricular canal,
and ventricles, and in doing so, establish a primaryepicardiumbyE10.5 in
themouse. Two days later, at E12.5, some of the primary epicardial cells
undergo an epithelial to mesenchymal transition to convert into highly
mobile and developmentally plastic EPDCs (Figure 1). These EPDCs
proceed to invade the subepicardial matrix and subsequently migrate
into the myocardium, where they differentiate into interstitial and
perivascular fibroblasts, as well as coronary smooth muscle cells.1,4
Identification of the origin and nature of the cell autonomous and
non-cell autonomous signals responsible for the EPDCs mobilization
and differentiation was not possible before the availability of refined
mouse genetic tools with the power to interrogate the functional
rolesof specificcell typesduringepicardial formation.Critical instructive
signals can reside within the epicardial cells themselves, and/or from
underlying cardiomyocyte, and/or endocardial cells. Cre/LoxP-based
recombination technologies have allowed for both cell lineage
tracing and conditional genetic gain-of-function and loss-of-function
manipulation with far greater specificity than systemic transgenic
approaches. Use of Cre/LoxP strategies has led to the discovery of a
number of autocrine and paracrine signalling pathways important for
epicardiogenesis and formation of EPDCs; however, the caveats of the
Cre/LoxP recombination system have proved to be problematic in the
interpretation of the generated data. The major challenge has always
been the need to consider the spatiotemporal expression patterns of
both the Cre driver line and the conditional alleles being investigate-
d.4,5Rudat et al.6 provide another provocative data set challenging our
interpretations of Cre/LoxP genetic manipulations of epicardial cell
biology.
Previous published findings show that canonical Wnt-,7,8 hedgehog
(HH)-,9 fibroblast growth factor (FGF)-,10 and platelet-derived growth
factor (PDGF)11-mediated signalling are important in epicardial and
EPDC development (Figure 1). A number of tissue-restricted Cre
mouse lineswerecritical indetermining the role for these signallingpath-
ways during epicardiogenesis. These Cre drivers include Gata5Cre,12
Tbx18Cre,13 Wt1GFP/Cre,14 and the tamoxifen-inducible Wt1CreERT2.14
The importance of these signalling pathways in regulating various devel-
opmental processes and organogenesis is well established, thus there
was little controversy with the idea that these near ubiquitously critical
signalling pathways were also crucial in epicardial formation and EPDC
differentiation. Rudat et al.15,16 re-evaluated these pathways within
the forming epicardium using the newly generated Tbx18Cre mice, and
found unexpectedly that canonical Wnt-, HH-, and FGF-mediated sig-
nalling all appear to be dispensable to epicardial development.6 These
new data stand contradictory to earlier findings,7–10,11 and may recali-
brate our current understanding of the signalling mechanisms that regu-
late the mobilization and differentiation of EPDCs. For example, in
previous studies, conditional inactivation of both FGF receptor 1
(Fgfr1) and FGF receptor 2 (Fgfr2) alleles using Wt1Cre resulted in
fewer EPDCs within the myocardium,10 suggesting a direct role of
FGF signalling regulatingEPDCcardiacmyofibroblast invasionanddiffer-
entiation within the embryonic myocardium. Within cardiomyocytes,
Fgfr1- and Fgfr2-mediated signalling were suggested to trigger a wave
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ofHHactivation thatwas essential for coronary vessel development.17 If
Rudat’s findings hold true, the influence of FGF on epicardial develop-
ment may most likely be the result of a non-cell autonomous FGF and
HH signalling centre residing within the underlying myocardium.
One of the obvious explanations for the differences between the
finding of Rudat et al. and previous reports are that the different Cre-
linesemployed in these studies havevariedcharacteristics in their spatio-
temporal expression, which results in distinct phenotypic outcomes.
The epicardial-restricted Gata5Cre and Wt1GFP/Cre mice utilized in early
studies cited above have been shown to display ectopic or leaky Cre
expression in themyocardiumaswell as othercell lineages such as endo-
cardial/endothelial andmyocardial cells of thedeveloping heart.12,14 The
tamoxifen-inducibleWt1CreERT2 14 and the newly reported Tbx18Cre 15,16
epicardial Cre mouse lines are refined epicardially restricted lines;
however, Rudat et al. demonstrate clear differences between pheno-
types derived from utilizing these two Cre drivers. A probable explan-
ation for these discrepancies lies within the consideration of the Cre/
LoxP recombination efficiency between these Cre drivers and/or the
differences in genetic background and of course the influence and tem-
poral issues with tamoxifen induction. The new Tbx18Cre mouse line
mediates clean epicardial-restricted recombination at the right ventricle
side of the heart; however, on the left ventricle side, a subset of cardio-
myocytes in the intraventricular septum are also Cre positive, which is
consistent with a previous report.5 Thus, Rudat’s analysis focused only
on the epicardial structures on the right ventricular side of the heart,
which minimized the contribution of cardiomyocytes in their data sets.
Another possible explanation for thedata disparity is subtle (or not so
subtle) differences in the spatiotemporal expression patterns, i.e. the
timing and extent of genetic deletion within the early EPCs. A good
place to look for such important expressiondifferenceswouldbe theun-
differentiated mesodermal cells at the venous pole prior to the forma-
tion of PE.18 The current collection of Cre drivers (Gata5, Wt1, and
Tbx18) are all expressed within the mesoderm of the venous pole.
Therefore, it is possible that early difference inCre-mediated recombin-
ationwithin these undifferentiatedmesodermal cells prior to the PE for-
mation could have a great influence on phenotypic outcomes while
revealing little difference in lineage-mapping analysis. In support this
idea, bothTbx18 and Wt1 have been shown to express within a subset
of PE cells that are distinct from PE cells that express two epicardial
markers, Scleraxis (Scx) and Semaphorin3D (Sema3D),19 suggesting a
diversified heterogeneous population EPCs within PE that may not be
completely encompassed by the expression of any of the existing Cre
line. To move forward, additional experiments will be required to sort
out whether cells within the PE are a homogenous population of EPCs
or a diverse heterogeneous collection of cells that exhibit variations in
Cre activity between theWt1CreERT2 and Tbx18Cre mouse lines.
Although the use of mouse Cre/loxP-based genetic manipulation has
proved to be a powerful tool for dissecting various signalling pathways
governing the programmes that orchestrate embryonic organ develop-
mental, the work by Rudat et al. remind us once again the generation of
data is the easy part of the scientific process, and that the interpretations
ofCre-generated data are subjected to the pitfall and caveats ofwhatwe
donot knowregarding the reagentsweall employ, thuswewill undoubt-
edly be re-visiting the evaluation of the signalling pathways that govern
formation of the epicardium, EPDCs, and their derivative cell types for
some time to come.
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